Observational Study of Correction of Anaemia With Darbepoetin Alfa at Monthly Dose Frequency in EU and Australian Patients With Chronic Kidney Disease Not on Dialysis
Phase of Trial: Phase IV
Latest Information Update: 14 Mar 2016
Price : $35 *
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms ADAPTATION
- Sponsors Amgen
- 31 Aug 2018 Biomarkers information updated
- 28 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 18 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.